Olympic cyclist Lizzie Armitstead has married fellow cyclist Philip Deignan at a church in her hometown.Read the full story ›
Crowds of people have started to arrive at a church in Otley ahead of the wedding of world champion cyclist Lizzie Armitstead.
The Olympian, who won silver at London 2012, is due to marry professional cyclist Philip Deignan at The Bridge United Reformed Church. He popped the question last September after a year of dating.
A mother whose son died after being hit by a speeding drunk driver is backing the latest campaign for tougher sentences for motoristsRead the full story ›
The astronaut Tim Peake has been taking questions - about eating sweets in Space, and other things - put to him as he whizzed above the skies in the International Space Station, from a classroom in Otley. Here's far out Adam Fowler.
Children from a primary school in Otley have become the first in Yorkshire to speak live with British astronaut Tim Peake.Read the full story ›
After a long-fought campaign, the Vimizim drug to treat those with the ultra-rare disease Morquio Syndrome has today received final sign-off from health authorities.
Announcing the decision this morning, the National Institute of Health and Care Excellence (NICE) has published final guidance saying that Vimizim is now officially approved for use in the UK and can be funded by NHS England.
The #FundOurDrugsNOW campaign, led by Leeds North West MP Greg Mulholland, has spent the last 13 months demanding the drug is approved as soon as possible.
Mr Mulholland worked closely with families and charities, including the family of Otley seven year-old Sam Brown, to campaign for today’s news. Sam Brown is one of just 88 people in England with Morquio Syndrome.
"This is exactly the news we wanted and I am delighted for Sam and for all the people with Morquio who will now get access to the treatment they need.
"For 13 months, we have repeatedly demanded ministers, NHS England and NICE do what 20 other European countries have already done.
"And today, after a long-fought campaign, we are finally there.
"It is a great victory for people power and all those involved in the campaign including the MPS Society and families up and down the country.
“I am delighted for Sam Brown. Aged just seven, he has already been through so much. His parents Katy and Simon deserve so much credit for keeping up the fight.
"It has been a real pleasure to have worked with them and the announcement is a well-deserved early Christmas present.”
“We are relieved and delighted by today’s decision, and would like to thank Greg for his unwavering support.
"Without him, and the work of the MPS Society, none of this would have been possible.
"We would also like to thank our local community for the incredible and humbling support that we have received over the past year.
"We are now looking forward to a relaxing family Christmas, celebrating this victory and a much brighter future for Sam.”
The National Institute for Health and Care Excellence (NICE) has approved the use of the drug Vimizim to treat Morquio Syndrome, a rare and life-limiting genetic condition.
Today's news will be welcomed by the family of 7-year-old Sam Brown, who has the condition. Sam, from Otley in West Yorkshire, is one of just 88 people in England with Morquio condition. The drug was approved on a Europe-wide level in April 2014 and is already in use in 20 other European countries, but attempts to make it available in England have seen repeated delays.
However in November NICE reached an agreement with the NHS and the manufacturer, BioMarin, to provide Vimizim to patients who have the degenerative disease.
Morquio Syndrome is a degenerative disease where patients with the condition appear healthy at birth, but within 24-36 months start to show symptoms of severe problems. Average life expectancy of someone with Morquio Syndrome is just 25 years.
A little boy from West Yorkshire with a rare disease looks almost certain to be given the life-changing drug he needs after the health regulator announced it would be made available on the NHS.
Sam Brown from Otley has Morquio Syndrome which stunts his growth, saps his energy and reduces his life expectancy.
Today the pharmaceutical company which makes the drug Vimizin has revealed that the NHS has finally agreed to pay for the medicine for the next five years.
"We've really been through a horrendous 12 month period, a rollercoaster ride of some highs and many many lows. Just four or five months ago NICE were recommending that they weren't going to fund this drug and it felt like there was no way through that. We're now five months on and they're saying they are and there's a huge amount of hard work that's gone in to getting to that place."
It has taken years of campaigning - from local petitions to visits to the Prime Minister.
Click below to watch Sarah Clark's round-up of Sam's campaign to get his life-enhancing treatment.
Local MP Greg Mulholland has welcomed the news that people with Morquio Syndrome will be able to access the Vimizim drug through NHS England.
NHS England and NICE have today secured a five-year, fixed-fee agreement with the drugs company BioMarin for the Vimizim drug. The agreement is the first of its kind for securing access to treatments for ultra-rare diseases.
It is expected to be rubber-stamped on 16th December, after which point those diagnosed with Vimizim will be able to get immediate access to Vimizim.
7-year-old Sam Brown, who lives in Mr Mulholland's constituency, is one of just 88 people in England with Morquio condition. The drug was approved on a Europe-wide level in April 2014 and is already in use in 20 other European countries, but attempts to make it available in England have seen repeated delays.
Commenting on NHS England’s announcement, Greg Mulholland said:
“After 12 months of campaigning, today’s news is a huge victory. It will mean that those with Morquio Syndrome will finally be able to get the Vimizim drug through NHS England. Today’s news is what many Morquio sufferers and their families have waited a long time to hear. It is great news for Sam Brown, whose parents Katy and Simon have campaigned long and hard. The agreement announced today is the breakthrough we all wanted. When rubber-stamped on 16th December, the agreement will mean the Vimizim drug will be immediately available to everyone diagnosed with condition. We are all delighted at today’s news, it is exactly what we have been demanding for the last 12 months. I could not be happier for Sam and his family.”
It has been announced that people with Morquio Syndrome will have access to a life-changing drug for the next five years.
The National Institute for Health and Care Excellence (NICE) has reached an agreement with the NHS and the manufacturer BioMarin to provide Vimizim to patients who have the degenerative disease.
It follows a long battle by campaigners, including the family of seven-year-old Sam Brown from Otley, who was receiving the drug on a trial basis.
"The Morquio A community has been long awaiting this decision, which provides patients access to Vimizim, and we are relieved and elated to have resolution. With fewer than 80 people living with Morquio A syndrome in England, it is hard to comprehend what these patients and their families have been through over the last 18 months. Treatment to this community is so much more than just a therapy. It is hope for a future where their improved health allows them to reach their full potential."
Patients will be able to take the drug following assessment on a Managed Access Agreement.
The approval is subject to a two-week consultation.